|
|
regulation of lipoprotein lipase activity
|
GO:0051004 |
4 |
0.911
|
|
|
|
cellular lipid metabolic process
|
GO:0044255 |
323 |
0.745
|
Human Mouse |
|
|
sterol metabolic process
|
GO:0016125 |
58 |
0.733
|
|
|
|
regulation of plasma lipoprotein particle levels
|
GO:0097006 |
23 |
0.689
|
|
|
|
cholesterol metabolic process
|
GO:0008203 |
56 |
0.681
|
|
|
|
positive regulation of lipoprotein lipase activity
|
GO:0051006 |
3 |
0.494
|
|
|
|
regulation of cholesterol metabolic process
|
GO:0090181 |
14 |
0.454
|
|
|
|
regulation of cellular ketone metabolic process
|
GO:0010565 |
66 |
0.437
|
|
|
|
plasma lipoprotein particle clearance
|
GO:0034381 |
13 |
0.404
|
|
|
|
positive regulation of triglyceride lipase activity
|
GO:0061365 |
3 |
0.353
|
|
|
|
regulation of hydrolase activity
|
GO:0051336 |
246 |
0.322
|
|
|
|
cellular amino acid metabolic process
|
GO:0006520 |
103 |
0.239
|
|
|
|
steroid metabolic process
|
GO:0008202 |
119 |
0.230
|
|
|
|
triglyceride metabolic process
|
GO:0006641 |
51 |
0.221
|
|
|
|
regulation of defense response
|
GO:0031347 |
233 |
0.209
|
|
|
|
regulation of transferase activity
|
GO:0051338 |
263 |
0.206
|
|
|
|
macromolecule glycosylation
|
GO:0043413 |
55 |
0.198
|
|
|
|
small molecule catabolic process
|
GO:0044282 |
71 |
0.198
|
|
|
|
acylglycerol metabolic process
|
GO:0006639 |
55 |
0.195
|
|
|
|
regulation of triglyceride metabolic process
|
GO:0090207 |
17 |
0.179
|
|
|
|
urogenital system development
|
GO:0001655 |
261 |
0.176
|
|
|
|
response to organonitrogen compound
|
GO:0010243 |
246 |
0.168
|
|
|
|
regulation of lipase activity
|
GO:0060191 |
15 |
0.161
|
|
|
|
positive regulation of triglyceride metabolic process
|
GO:0090208 |
9 |
0.154
|
|
|
|
glycerolipid metabolic process
|
GO:0046486 |
122 |
0.146
|
Human |
|
|
neutral lipid metabolic process
|
GO:0006638 |
57 |
0.146
|
|
|
|
lipid catabolic process
|
GO:0016042 |
69 |
0.144
|
|
|
|
amine metabolic process
|
GO:0009308 |
45 |
0.144
|
Human |
|
|
blood vessel morphogenesis
|
GO:0048514 |
285 |
0.142
|
|
|
|
cellular amine metabolic process
|
GO:0044106 |
44 |
0.142
|
Human |
|
|
transmembrane transport
|
GO:0055085 |
412 |
0.138
|
|
|
|
peptidyl amino acid modification
|
GO:0018193 |
336 |
0.137
|
|
|
|
synaptic transmission
|
GO:0007268 |
329 |
0.134
|
|
|
|
cellular ketone metabolic process
|
GO:0042180 |
84 |
0.130
|
|
|
|
cell adhesion
|
GO:0007155 |
329 |
0.128
|
|
|
|
regulation of kinase activity
|
GO:0043549 |
249 |
0.127
|
|
|
|
alcohol metabolic process
|
GO:0006066 |
116 |
0.122
|
|
|
|
regulation of response to wounding
|
GO:1903034 |
189 |
0.122
|
|
|
|
regulation of cellular amine metabolic process
|
GO:0033238 |
20 |
0.121
|
|
|
|
protein maturation
|
GO:0051604 |
176 |
0.119
|
|
|
|
angiogenesis
|
GO:0001525 |
201 |
0.118
|
|
|
|
cellular response to peptide hormone stimulus
|
GO:0071375 |
92 |
0.116
|
|
|
|
cellular lipid catabolic process
|
GO:0044242 |
52 |
0.115
|
|
|
|
regulation of cellular amino acid metabolic process
|
GO:0006521 |
5 |
0.112
|
|
|
|
cellular response to peptide
|
GO:1901653 |
92 |
0.112
|
|
|
|
cellular response to organonitrogen compound
|
GO:0071417 |
145 |
0.111
|
|
|
|
cytokine production
|
GO:0001816 |
319 |
0.110
|
|
|
|
fat cell differentiation
|
GO:0045444 |
160 |
0.109
|
|
|
|
negative regulation of molecular function
|
GO:0044092 |
258 |
0.108
|
|
|
|
response to peptide hormone
|
GO:0043434 |
127 |
0.108
|
|
|
|
glycoprotein biosynthetic process
|
GO:0009101 |
89 |
0.108
|
|
|
|
regulation of homeostatic process
|
GO:0032844 |
182 |
0.107
|
|
|
|
protein glycosylation
|
GO:0006486 |
55 |
0.104
|
|
|
|
negative regulation of protein metabolic process
|
GO:0051248 |
282 |
0.103
|
|
|
|
positive regulation of kinase activity
|
GO:0033674 |
155 |
0.103
|
|
|
|
wound healing
|
GO:0042060 |
157 |
0.103
|
|
|
|
regulation of lipid metabolic process
|
GO:0019216 |
118 |
0.099
|
|
|
|
positive regulation of lipid metabolic process
|
GO:0045834 |
40 |
0.098
|
|
|
|
glycoprotein metabolic process
|
GO:0009100 |
116 |
0.097
|
|
|
|
sterol transmembrane transport
|
GO:0035382 |
2 |
0.096
|
|
|
|
regulation of protein kinase activity
|
GO:0045859 |
232 |
0.095
|
|
|
|
organonitrogen compound catabolic process
|
GO:1901565 |
264 |
0.093
|
|
|
|
glycerolipid biosynthetic process
|
GO:0045017 |
50 |
0.092
|
Human |
|
|
regulation of organelle organization
|
GO:0033043 |
289 |
0.089
|
|
|
|
positive regulation of cellular amine metabolic process
|
GO:0033240 |
5 |
0.088
|
|
|
|
carboxylic acid catabolic process
|
GO:0046395 |
51 |
0.088
|
|
|
|
monocarboxylic acid metabolic process
|
GO:0032787 |
191 |
0.088
|
|
|
|
regulation of mapk cascade
|
GO:0043408 |
248 |
0.086
|
|
|
|
cholesterol esterification
|
GO:0034435 |
3 |
0.082
|
Human |
|
|
peptidyl tyrosine modification
|
GO:0018212 |
145 |
0.082
|
|
|
|
regulation of cellular catabolic process
|
GO:0031329 |
242 |
0.082
|
|
|
|
anatomical structure homeostasis
|
GO:0060249 |
145 |
0.079
|
|
|
|
glycosylation
|
GO:0070085 |
62 |
0.078
|
|
|
|
regulation of cell motility
|
GO:2000145 |
236 |
0.078
|
|
|
|
organic anion transport
|
GO:0015711 |
137 |
0.078
|
|
|
|
mapk cascade
|
GO:0000165 |
281 |
0.078
|
|
|
|
regulation of cell migration
|
GO:0030334 |
219 |
0.078
|
|
|
|
cytoplasmic transport
|
GO:0016482 |
234 |
0.077
|
|
|
|
rho protein signal transduction
|
GO:0007266 |
32 |
0.075
|
|
|
|
organonitrogen compound biosynthetic process
|
GO:1901566 |
192 |
0.075
|
Human |
|
|
regulation of proteolysis
|
GO:0030162 |
164 |
0.073
|
|
|
|
regulation of neuron projection development
|
GO:0010975 |
169 |
0.072
|
|
|
|
immune effector process
|
GO:0002252 |
321 |
0.072
|
|
|
|
regulation of protein serine threonine kinase activity
|
GO:0071900 |
157 |
0.072
|
|
|
|
cytokine mediated signaling pathway
|
GO:0019221 |
115 |
0.071
|
|
|
|
ras protein signal transduction
|
GO:0007265 |
77 |
0.069
|
|
|
|
positive regulation of protein kinase activity
|
GO:0045860 |
144 |
0.068
|
|
|
|
kidney development
|
GO:0001822 |
213 |
0.067
|
|
|
|
carbohydrate derivative biosynthetic process
|
GO:1901137 |
183 |
0.067
|
|
|
|
inflammatory response
|
GO:0006954 |
244 |
0.067
|
|
|
|
regulation of cytokine production
|
GO:0001817 |
266 |
0.066
|
|
|
|
regulation of cell projection organization
|
GO:0031344 |
206 |
0.066
|
|
|
|
regulation of inflammatory response
|
GO:0050727 |
147 |
0.066
|
|
|
|
small gtpase mediated signal transduction
|
GO:0007264 |
97 |
0.066
|
|
|
|
regulation of cell activation
|
GO:0050865 |
289 |
0.065
|
|
|
|
blood circulation
|
GO:0008015 |
195 |
0.065
|
|
|
|
dephosphorylation
|
GO:0016311 |
129 |
0.065
|
|
|
|
chemotaxis
|
GO:0006935 |
247 |
0.064
|
|
|
|
negative regulation of cellular component organization
|
GO:0051129 |
194 |
0.064
|
|
|
|
positive regulation of nervous system development
|
GO:0051962 |
221 |
0.064
|
|
|
|
positive regulation of protein phosphorylation
|
GO:0001934 |
242 |
0.063
|
|
|
|
positive regulation of transferase activity
|
GO:0051347 |
167 |
0.063
|
|
|
|
regulation of cellular component biogenesis
|
GO:0044087 |
181 |
0.063
|
|
|
|
glycerophospholipid metabolic process
|
GO:0006650 |
71 |
0.062
|
Human |
|
|
carbohydrate metabolic process
|
GO:0005975 |
230 |
0.061
|
|
|
|
positive regulation of neuron differentiation
|
GO:0045666 |
141 |
0.061
|
|
|
|
striated muscle tissue development
|
GO:0014706 |
293 |
0.061
|
|
|
|
g protein coupled receptor signaling pathway
|
GO:0007186 |
243 |
0.061
|
|
|
|
regulation of insulin receptor signaling pathway
|
GO:0046626 |
21 |
0.060
|
|
|
|
positive regulation of cellular amino acid metabolic process
|
GO:0045764 |
3 |
0.060
|
|
|
|
lipid biosynthetic process
|
GO:0008610 |
179 |
0.060
|
Human |
|
|
transmembrane receptor protein tyrosine kinase signaling pathway
|
GO:0007169 |
247 |
0.059
|
|
|
|
circulatory system process
|
GO:0003013 |
197 |
0.058
|
|
|
|
nucleobase containing small molecule metabolic process
|
GO:0055086 |
352 |
0.057
|
|
|
|
regulation of anatomical structure size
|
GO:0090066 |
178 |
0.057
|
|
|
|
response to insulin
|
GO:0032868 |
100 |
0.057
|
|
|
|
neuron apoptotic process
|
GO:0051402 |
142 |
0.057
|
|
|
|
fatty acid metabolic process
|
GO:0006631 |
121 |
0.057
|
|
|
|
lipoprotein metabolic process
|
GO:0042157 |
43 |
0.056
|
|
|
|
cholesterol import
|
GO:0070508 |
2 |
0.056
|
|
|
|
t cell activation
|
GO:0042110 |
289 |
0.055
|
|
|
|
heart morphogenesis
|
GO:0003007 |
178 |
0.055
|
|
|
|
c4 dicarboxylate transport
|
GO:0015740 |
3 |
0.055
|
|
|
|
positive regulation of hydrolase activity
|
GO:0051345 |
148 |
0.055
|
|
|
|
organelle fission
|
GO:0048285 |
170 |
0.054
|
|
|
|
protein processing
|
GO:0016485 |
163 |
0.054
|
|
|
|
positive regulation of mapk cascade
|
GO:0043410 |
170 |
0.054
|
|
|
|
regulation of peptidase activity
|
GO:0052547 |
96 |
0.053
|
|
|
|
regulation of peptidyl tyrosine phosphorylation
|
GO:0050730 |
93 |
0.052
|
|
|
|
myeloid cell differentiation
|
GO:0030099 |
233 |
0.052
|
|
|
|
phospholipid metabolic process
|
GO:0006644 |
87 |
0.052
|
Human |
|
|
renal system development
|
GO:0072001 |
225 |
0.052
|
|
|
|
forebrain development
|
GO:0030900 |
302 |
0.052
|
|
|
|
regulation of cytoskeleton organization
|
GO:0051493 |
122 |
0.051
|
|
|
|
skeletal system development
|
GO:0001501 |
356 |
0.051
|
|
|
|
cellular response to insulin stimulus
|
GO:0032869 |
78 |
0.051
|
|
|
|
protein secretion
|
GO:0009306 |
111 |
0.051
|
|
|
|
regulation of phosphatidylcholine catabolic process
|
GO:0010899 |
2 |
0.050
|
|
|
|
response to organic cyclic compound
|
GO:0014070 |
198 |
0.050
|
Rat |
|
|
organ growth
|
GO:0035265 |
117 |
0.050
|
|
|
|
regulation of cell morphogenesis involved in differentiation
|
GO:0010769 |
151 |
0.050
|
|
|
|
amino acid transport
|
GO:0006865 |
61 |
0.050
|
|
|
|
maintenance of location
|
GO:0051235 |
89 |
0.050
|
|
|
|
vascular process in circulatory system
|
GO:0003018 |
62 |
0.049
|
|
|
|
organic hydroxy compound metabolic process
|
GO:1901615 |
203 |
0.049
|
|
|
|
positive regulation of organelle organization
|
GO:0010638 |
128 |
0.049
|
|
|
|
positive regulation of cellular component biogenesis
|
GO:0044089 |
94 |
0.049
|
|
|
|
organophosphate ester transport
|
GO:0015748 |
28 |
0.049
|
|
|
|
nucleotide metabolic process
|
GO:0009117 |
332 |
0.049
|
|
|
|
organic cyclic compound catabolic process
|
GO:1901361 |
295 |
0.049
|
|
|
|
negative regulation of cellular amino acid metabolic process
|
GO:0045763 |
0 |
0.049
|
|
|
|
organophosphate catabolic process
|
GO:0046434 |
232 |
0.048
|
|
|
|
positive regulation of cell development
|
GO:0010720 |
237 |
0.048
|
|
|
|
positive regulation of protein serine threonine kinase activity
|
GO:0071902 |
106 |
0.048
|
|
|
|
sensory organ morphogenesis
|
GO:0090596 |
242 |
0.048
|
|
|
|
reactive oxygen species metabolic process
|
GO:0072593 |
84 |
0.048
|
|
|
|
negative regulation of cellular protein metabolic process
|
GO:0032269 |
247 |
0.047
|
|
|
|
negative regulation of cellular amine metabolic process
|
GO:0033239 |
1 |
0.047
|
|
|
|
nuclear division
|
GO:0000280 |
158 |
0.047
|
|
|
|
positive regulation of cytokine production
|
GO:0001819 |
174 |
0.047
|
|
|
|
neutral lipid biosynthetic process
|
GO:0046460 |
18 |
0.047
|
|
|
|
cellular chemical homeostasis
|
GO:0055082 |
215 |
0.047
|
|
|
|
tissue remodeling
|
GO:0048771 |
102 |
0.046
|
|
|
|
cellular response to hormone stimulus
|
GO:0032870 |
150 |
0.046
|
|
|
|
positive regulation of lipid biosynthetic process
|
GO:0046889 |
18 |
0.046
|
|
|
|
regulation of secretion
|
GO:0051046 |
274 |
0.046
|
|
|
|
positive regulation of protein modification process
|
GO:0031401 |
299 |
0.046
|
|
|
|
camera type eye development
|
GO:0043010 |
266 |
0.045
|
|
|
|
response to peptide
|
GO:1901652 |
136 |
0.045
|
|
|
|
organic acid catabolic process
|
GO:0016054 |
51 |
0.045
|
|
|
|
negative regulation of phosphorus metabolic process
|
GO:0010563 |
184 |
0.045
|
|
|
|
negative regulation of phosphorylation
|
GO:0042326 |
166 |
0.045
|
|
|
|
organic hydroxy compound transport
|
GO:0015850 |
93 |
0.044
|
Human |
|
|
regulation of lymphocyte activation
|
GO:0051249 |
240 |
0.044
|
|
|
|
regulation of neuron differentiation
|
GO:0045664 |
281 |
0.044
|
|
|
|
vasodilation
|
GO:0042311 |
28 |
0.044
|
|
|
|
negative regulation of growth
|
GO:0045926 |
99 |
0.044
|
|
|
|
regulation of ras protein signal transduction
|
GO:0046578 |
114 |
0.044
|
|
|
|
ribonucleoside metabolic process
|
GO:0009119 |
245 |
0.044
|
|
|
|
establishment of blood nerve barrier
|
GO:0008065 |
3 |
0.043
|
|
|
|
regulation of secretion by cell
|
GO:1903530 |
249 |
0.043
|
|
|
|
regulation of lipid catabolic process
|
GO:0050994 |
15 |
0.043
|
|
|
|
leukocyte migration
|
GO:0050900 |
124 |
0.043
|
|
|
|
embryonic organ morphogenesis
|
GO:0048562 |
276 |
0.041
|
|
|
|
regulation of cell adhesion
|
GO:0030155 |
154 |
0.041
|
|
|
|
positive regulation of insulin receptor signaling pathway
|
GO:0046628 |
4 |
0.041
|
|
|
|
activation of mapk activity
|
GO:0000187 |
59 |
0.041
|
|
|
|
negative regulation of cell development
|
GO:0010721 |
169 |
0.041
|
|
|
|
protein localization to nucleus
|
GO:0034504 |
121 |
0.041
|
|
|
|
regulation of blood vessel size
|
GO:0050880 |
56 |
0.040
|
|
|
|
regulation of reactive oxygen species metabolic process
|
GO:2000377 |
40 |
0.040
|
|
|
|
hexose metabolic process
|
GO:0019318 |
98 |
0.040
|
|
|
|
positive regulation of cell morphogenesis involved in differentiation
|
GO:0010770 |
72 |
0.040
|
|
|
|
innate immune response
|
GO:0045087 |
157 |
0.040
|
|
|
|
regulation of hormone levels
|
GO:0010817 |
211 |
0.040
|
|
|
|
nucleoside phosphate metabolic process
|
GO:0006753 |
338 |
0.039
|
|
|
|
ossification
|
GO:0001503 |
216 |
0.039
|
|
|
|
positive regulation of cellular catabolic process
|
GO:0031331 |
148 |
0.039
|
|
|
|
neuron death
|
GO:0070997 |
154 |
0.039
|
|
|
|
muscle cell differentiation
|
GO:0042692 |
261 |
0.039
|
|
|
|
positive regulation of growth
|
GO:0045927 |
104 |
0.039
|
|
|
|
negative regulation of neuron apoptotic process
|
GO:0043524 |
92 |
0.038
|
|
|
|
carbohydrate transport
|
GO:0008643 |
62 |
0.038
|
|
|
|
phospholipid catabolic process
|
GO:0009395 |
5 |
0.038
|
|
|
|
positive regulation of defense response
|
GO:0031349 |
124 |
0.038
|
|
|
|
purine ribonucleotide metabolic process
|
GO:0009150 |
290 |
0.038
|
|
|
|
epithelial cell development
|
GO:0002064 |
159 |
0.037
|
|
|
|
platelet derived growth factor receptor signaling pathway
|
GO:0048008 |
32 |
0.037
|
|
|
|
purine containing compound metabolic process
|
GO:0072521 |
311 |
0.037
|
|
|
|
gland development
|
GO:0048732 |
330 |
0.037
|
|
|
|
regulation of endopeptidase activity
|
GO:0052548 |
89 |
0.037
|
|
|
|
regulation of map kinase activity
|
GO:0043405 |
120 |
0.037
|
|
|
|
regulation of rho protein signal transduction
|
GO:0035023 |
71 |
0.037
|
|
|
|
negative regulation of hydrolase activity
|
GO:0051346 |
71 |
0.037
|
|
|
|
organic acid transport
|
GO:0015849 |
101 |
0.037
|
|
|
|
nucleoside catabolic process
|
GO:0009164 |
206 |
0.037
|
|
|
|
cation homeostasis
|
GO:0055080 |
212 |
0.037
|
|
|
|
negative regulation of neuron projection development
|
GO:0010977 |
50 |
0.037
|
|
|
|
cell chemotaxis
|
GO:0060326 |
81 |
0.037
|
|
|
|
oxidation reduction process
|
GO:0055114 |
342 |
0.037
|
|
|
|
stem cell differentiation
|
GO:0048863 |
268 |
0.036
|
|
|
|
single organismal cell cell adhesion
|
GO:0016337 |
131 |
0.036
|
|
|
|
glycerolipid catabolic process
|
GO:0046503 |
16 |
0.036
|
|
|
|
activation of immune response
|
GO:0002253 |
138 |
0.036
|
|
|
|
pallium development
|
GO:0021543 |
120 |
0.036
|
|
|
|
small molecule biosynthetic process
|
GO:0044283 |
132 |
0.036
|
Human |
|
|
positive regulation of creb transcription factor activity
|
GO:0032793 |
4 |
0.036
|
|
|
|
negative regulation of endopeptidase activity
|
GO:0010951 |
44 |
0.035
|
|
|
|
adaptive immune response
|
GO:0002250 |
155 |
0.035
|
|
|
|
regulation of neuron apoptotic process
|
GO:0043523 |
122 |
0.035
|
|
|
|
purine nucleotide catabolic process
|
GO:0006195 |
211 |
0.035
|
|
|
|
glucose homeostasis
|
GO:0042593 |
128 |
0.034
|
|
|
|
actin filament organization
|
GO:0007015 |
113 |
0.034
|
|
|
|
organic acid biosynthetic process
|
GO:0016053 |
86 |
0.034
|
|
|
|
membrane organization
|
GO:0061024 |
245 |
0.034
|
|
|
|
multicellular organismal homeostasis
|
GO:0048871 |
164 |
0.034
|
|
|
|
sterol esterification
|
GO:0034434 |
3 |
0.034
|
Human |
|
|
forebrain cell migration
|
GO:0021885 |
58 |
0.033
|
|
|
|
regulation of protein processing
|
GO:0070613 |
96 |
0.033
|
|
|
|
cell type specific apoptotic process
|
GO:0097285 |
268 |
0.033
|
|
|
|
germ cell development
|
GO:0007281 |
185 |
0.033
|
|
|
|
regulation of protein localization
|
GO:0032880 |
231 |
0.033
|
|
|
|
positive regulation of cell activation
|
GO:0050867 |
158 |
0.033
|
|
|
|
regulation of lipid biosynthetic process
|
GO:0046890 |
54 |
0.033
|
|
|
|
response to amino acid
|
GO:0043200 |
37 |
0.033
|
|
|
|
negative regulation of protein processing
|
GO:0010955 |
79 |
0.033
|
|
|
|
regulation of actin cytoskeleton organization
|
GO:0032956 |
84 |
0.032
|
|
|
|
cerebral cortex development
|
GO:0021987 |
86 |
0.032
|
|
|
|
cation transport
|
GO:0006812 |
399 |
0.032
|
|
|
|
t cell differentiation
|
GO:0030217 |
174 |
0.032
|
|
|
|
regulation of fat cell differentiation
|
GO:0045598 |
81 |
0.031
|
|
|
|
ribonucleotide metabolic process
|
GO:0009259 |
291 |
0.031
|
|
|
|
telencephalon development
|
GO:0021537 |
186 |
0.031
|
|
|
|
purine ribonucleoside triphosphate metabolic process
|
GO:0009205 |
220 |
0.031
|
|
|
|
adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains
|
GO:0002460 |
145 |
0.031
|
|
|
|
positive regulation of reactive oxygen species metabolic process
|
GO:2000379 |
11 |
0.031
|
|
|
|
negative regulation of neuron death
|
GO:1901215 |
98 |
0.031
|
|
|
|
negative regulation of protein phosphorylation
|
GO:0001933 |
126 |
0.031
|
|
|
|
chromatin organization
|
GO:0006325 |
206 |
0.030
|
|
|
|
regulation of purine nucleotide metabolic process
|
GO:1900542 |
169 |
0.030
|
|
|
|
lipid localization
|
GO:0010876 |
126 |
0.030
|
Human |
|
|
negative regulation of cell proliferation
|
GO:0008285 |
296 |
0.030
|
|
|
|
regulation of metal ion transport
|
GO:0010959 |
106 |
0.030
|
|
|
|
apoptotic signaling pathway
|
GO:0097190 |
306 |
0.030
|
|
|
|
negative regulation of intracellular signal transduction
|
GO:1902532 |
167 |
0.030
|
|
|
|
chromatin modification
|
GO:0016568 |
187 |
0.030
|
|
|
|
purine nucleotide metabolic process
|
GO:0006163 |
302 |
0.030
|
|
|
|
negative regulation of phosphate metabolic process
|
GO:0045936 |
184 |
0.030
|
|
|
|
regulation of triglyceride biosynthetic process
|
GO:0010866 |
10 |
0.030
|
|
|
|
positive regulation of homeostatic process
|
GO:0032846 |
64 |
0.030
|
|
|
|
embryonic placenta development
|
GO:0001892 |
98 |
0.029
|
|
|
|
regulation of actin filament based process
|
GO:0032970 |
99 |
0.029
|
|
|
|
organic hydroxy compound biosynthetic process
|
GO:1901617 |
77 |
0.029
|
Human |
|
|
reactive nitrogen species metabolic process
|
GO:2001057 |
0 |
0.029
|
|
|
|
cellular nitrogen compound catabolic process
|
GO:0044270 |
280 |
0.029
|
|
|
|
negative regulation of nervous system development
|
GO:0051961 |
156 |
0.029
|
|
|
|
ribonucleoside triphosphate metabolic process
|
GO:0009199 |
220 |
0.029
|
|
|
|
actin cytoskeleton organization
|
GO:0030036 |
220 |
0.029
|
|
|
|
anion transport
|
GO:0006820 |
177 |
0.029
|
|
|
|
brown fat cell differentiation
|
GO:0050873 |
36 |
0.029
|
|
|
|
positive regulation of map kinase activity
|
GO:0043406 |
84 |
0.029
|
|
|
|
nitrogen compound transport
|
GO:0071705 |
271 |
0.029
|
|
|
|
calcium ion homeostasis
|
GO:0055074 |
127 |
0.029
|
|
|
|
nucleoside metabolic process
|
GO:0009116 |
246 |
0.028
|
|
|
|
cellular metal ion homeostasis
|
GO:0006875 |
151 |
0.028
|
|
|
|
sequestering of calcium ion
|
GO:0051208 |
18 |
0.028
|
|
|
|
negative regulation of protein modification process
|
GO:0031400 |
163 |
0.028
|
|
|
|
positive regulation of immune effector process
|
GO:0002699 |
107 |
0.028
|
|
|
|
axonogenesis
|
GO:0007409 |
274 |
0.028
|
|
|
|
nucleoside triphosphate metabolic process
|
GO:0009141 |
230 |
0.028
|
|
|
|
positive regulation of programmed cell death
|
GO:0043068 |
218 |
0.028
|
|
|
|
positive regulation of lymphocyte activation
|
GO:0051251 |
140 |
0.028
|
|
|
|
carbohydrate derivative catabolic process
|
GO:1901136 |
231 |
0.028
|
|
|
|
hexose transport
|
GO:0008645 |
56 |
0.028
|
|
|
|
connective tissue development
|
GO:0061448 |
179 |
0.028
|
|
|
|
sterol import
|
GO:0035376 |
2 |
0.028
|
|
|
|
regulation of coagulation
|
GO:0050818 |
31 |
0.028
|
|
|
|
morphogenesis of a branching structure
|
GO:0001763 |
203 |
0.028
|
|
|
|
sterol transport
|
GO:0015918 |
38 |
0.028
|
Human |
|
|
tissue homeostasis
|
GO:0001894 |
115 |
0.028
|
|
|
|
carbohydrate homeostasis
|
GO:0033500 |
128 |
0.027
|
|
|
|
muscle tissue development
|
GO:0060537 |
308 |
0.027
|
|
|
|
digestive tract development
|
GO:0048565 |
190 |
0.027
|
|
|
|
renal system process
|
GO:0003014 |
48 |
0.027
|
|
|
|
cellular divalent inorganic cation homeostasis
|
GO:0072503 |
127 |
0.027
|
|
|
|
extracellular structure organization
|
GO:0043062 |
148 |
0.027
|
|
|
|
cellular response to growth factor stimulus
|
GO:0071363 |
197 |
0.027
|
|
|
|
hematopoietic progenitor cell differentiation
|
GO:0002244 |
143 |
0.027
|
|
|
|
response to inorganic substance
|
GO:0010035 |
96 |
0.027
|
Rat |
|
|
response to growth factor
|
GO:0070848 |
198 |
0.027
|
|
|
|
female gamete generation
|
GO:0007292 |
74 |
0.027
|
|
|
|
positive regulation of t cell activation
|
GO:0050870 |
101 |
0.027
|
|
|
|
cellular response to cytokine stimulus
|
GO:0071345 |
189 |
0.027
|
|
|
|
cardiac muscle tissue development
|
GO:0048738 |
130 |
0.026
|
|
|
|
purine ribonucleotide catabolic process
|
GO:0009154 |
208 |
0.026
|
|
|
|
nucleoside triphosphate catabolic process
|
GO:0009143 |
205 |
0.026
|
|
|
|
regulation of lymphocyte differentiation
|
GO:0045619 |
107 |
0.026
|
|
|
|
purine ribonucleoside metabolic process
|
GO:0046128 |
241 |
0.026
|
|
|
|
sterol homeostasis
|
GO:0055092 |
45 |
0.026
|
Human |
|
|
dicarboxylic acid transport
|
GO:0006835 |
29 |
0.026
|
|
|
|
cardiocyte differentiation
|
GO:0035051 |
87 |
0.026
|
|
|
|
regulation of ras gtpase activity
|
GO:0032318 |
88 |
0.026
|
|
|
|
negative regulation of protein maturation
|
GO:1903318 |
79 |
0.026
|
|
|
|
regulation of bone remodeling
|
GO:0046850 |
28 |
0.026
|
|
|
|
negative regulation of response to wounding
|
GO:1903035 |
77 |
0.026
|
|
|
|
dendritic spine organization
|
GO:0097061 |
26 |
0.026
|
|
|
|
heart contraction
|
GO:0060047 |
93 |
0.026
|
|
|
|
acylglycerol biosynthetic process
|
GO:0046463 |
18 |
0.026
|
|
|
|
epidermis development
|
GO:0008544 |
187 |
0.026
|
|
|
|
lymphocyte differentiation
|
GO:0030098 |
242 |
0.026
|
|
|
|
activation of nf kappab inducing kinase activity
|
GO:0007250 |
4 |
0.026
|
|
|
|
regulation of blood coagulation
|
GO:0030193 |
28 |
0.026
|
|
|
|
glycosyl compound metabolic process
|
GO:1901657 |
246 |
0.026
|
|
|
|
regulation of steroid metabolic process
|
GO:0019218 |
39 |
0.026
|
|
|
|
ion transmembrane transport
|
GO:0034220 |
361 |
0.026
|
|
|
|
mitochondrion organization
|
GO:0007005 |
134 |
0.025
|
|
|
|
regulation of t cell activation
|
GO:0050863 |
170 |
0.025
|
|
|
|
ribonucleoside catabolic process
|
GO:0042454 |
206 |
0.025
|
|
|
|
regulation of protein maturation
|
GO:1903317 |
96 |
0.025
|
|
|
|
regulation of system process
|
GO:0044057 |
200 |
0.025
|
|
|
|
cell growth
|
GO:0016049 |
130 |
0.025
|
|
|
|
negative regulation of proteolysis
|
GO:0045861 |
74 |
0.025
|
|
|
|
male gamete generation
|
GO:0048232 |
285 |
0.025
|
|
|
|
response to oxidative stress
|
GO:0006979 |
123 |
0.025
|
|
|
|
monosaccharide transport
|
GO:0015749 |
58 |
0.025
|
|
|
|
response to monosaccharide
|
GO:0034284 |
67 |
0.025
|
|
|
|
lymphocyte mediated immunity
|
GO:0002449 |
139 |
0.025
|
|
|
|
glycosyl compound catabolic process
|
GO:1901658 |
206 |
0.025
|
|
|
|
leukocyte activation involved in immune response
|
GO:0002366 |
126 |
0.025
|
|
|
|
regulation of ion homeostasis
|
GO:2000021 |
64 |
0.024
|
|
|
|
single organism cell adhesion
|
GO:0098602 |
156 |
0.024
|
|
|
|
multicellular organism growth
|
GO:0035264 |
161 |
0.024
|
|
|
|
regulation of ion transport
|
GO:0043269 |
215 |
0.024
|
|
|
|
regulation of cell cycle
|
GO:0051726 |
281 |
0.024
|
|
|
|
cofactor metabolic process
|
GO:0051186 |
80 |
0.024
|
|
|
|
epithelial tube morphogenesis
|
GO:0060562 |
303 |
0.024
|
|
|
|
layer formation in cerebral cortex
|
GO:0021819 |
13 |
0.024
|
|
|
|
steroid esterification
|
GO:0034433 |
3 |
0.024
|
Human |
|
|
placenta development
|
GO:0001890 |
140 |
0.024
|
|
|
|
spermatogenesis
|
GO:0007283 |
284 |
0.024
|
|
|
|
glial cell differentiation
|
GO:0010001 |
131 |
0.024
|
|
|
|
regulation of tissue remodeling
|
GO:0034103 |
38 |
0.024
|
|
|
|
regulation of phospholipid catabolic process
|
GO:0060696 |
2 |
0.024
|
|
|
|
regulation of hemostasis
|
GO:1900046 |
28 |
0.024
|
|
|
|
metal ion homeostasis
|
GO:0055065 |
189 |
0.024
|
|
|
|
mitotic cell cycle
|
GO:0000278 |
195 |
0.024
|
|
|
|
nucleoside phosphate catabolic process
|
GO:1901292 |
222 |
0.024
|
|
|
|
cell maturation
|
GO:0048469 |
127 |
0.024
|
|
|
|
skeletal muscle organ development
|
GO:0060538 |
163 |
0.024
|
|
|
|
regulation of nucleotide metabolic process
|
GO:0006140 |
169 |
0.024
|
|
|
|
leukocyte mediated immunity
|
GO:0002443 |
174 |
0.024
|
|
|
|
mitotic cell cycle process
|
GO:1903047 |
159 |
0.024
|
|
|
|
divalent metal ion transport
|
GO:0070838 |
172 |
0.024
|
|
|
|
regulation of cellular response to stress
|
GO:0080135 |
159 |
0.024
|
|
|
|
septum primum development
|
GO:0003284 |
4 |
0.024
|
|
|
|
macromolecule catabolic process
|
GO:0009057 |
281 |
0.023
|
|
|
|
limbic system development
|
GO:0021761 |
72 |
0.023
|
|
|
|
ribose phosphate metabolic process
|
GO:0019693 |
291 |
0.023
|
|
|
|
dna metabolic process
|
GO:0006259 |
303 |
0.023
|
|
|
|
phospholipid transport
|
GO:0015914 |
21 |
0.023
|
|
|
|
response to corticosterone
|
GO:0051412 |
1 |
0.023
|
|
|
|
response to lipopolysaccharide
|
GO:0032496 |
128 |
0.023
|
|
|
|
peptidyl tyrosine phosphorylation
|
GO:0018108 |
143 |
0.023
|
|
|
|
positive regulation of leukocyte differentiation
|
GO:1902107 |
86 |
0.023
|
|
|
|
phosphatidylinositol mediated signaling
|
GO:0048015 |
41 |
0.023
|
|
|
|
cellular amino acid catabolic process
|
GO:0009063 |
25 |
0.023
|
|
|
|
regulation of apoptotic signaling pathway
|
GO:2001233 |
197 |
0.023
|
|
|
|
positive regulation of response to wounding
|
GO:1903036 |
66 |
0.023
|
|
|
|
purine ribonucleoside catabolic process
|
GO:0046130 |
205 |
0.023
|
|
|
|
triglyceride biosynthetic process
|
GO:0019432 |
17 |
0.023
|
|
|
|
regulation of membrane potential
|
GO:0042391 |
192 |
0.022
|
|
|
|
regulation of neuron death
|
GO:1901214 |
134 |
0.022
|
|
|
|
alcohol catabolic process
|
GO:0046164 |
16 |
0.022
|
|
|
|
positive regulation of cell projection organization
|
GO:0031346 |
95 |
0.022
|
|
|
|
negative regulation of dendritic spine development
|
GO:0061000 |
3 |
0.022
|
|
|
|
negative regulation of immune system process
|
GO:0002683 |
209 |
0.022
|
|
|
|
purine nucleoside triphosphate catabolic process
|
GO:0009146 |
203 |
0.022
|
|
|
|
oogenesis
|
GO:0048477 |
56 |
0.022
|
|
|
|
ear development
|
GO:0043583 |
200 |
0.022
|
|
|
|
transmission of nerve impulse
|
GO:0019226 |
76 |
0.022
|
|
|
|
nucleotide catabolic process
|
GO:0009166 |
217 |
0.022
|
|
|
|
extrinsic apoptotic signaling pathway
|
GO:0097191 |
126 |
0.022
|
|
|
|
blood coagulation
|
GO:0007596 |
76 |
0.022
|
|
|
|
multicellular organismal signaling
|
GO:0035637 |
91 |
0.022
|
|
|
|
regulation of feeding behavior
|
GO:0060259 |
3 |
0.022
|
|
|
|
regulation of nuclear division
|
GO:0051783 |
56 |
0.022
|
|
|
|
calcium ion transport
|
GO:0006816 |
159 |
0.022
|
|
|
|
regulation of activation of jak2 kinase activity
|
GO:0010534 |
1 |
0.022
|
|
|
|
cell activation involved in immune response
|
GO:0002263 |
126 |
0.022
|
|
|
|
purine containing compound catabolic process
|
GO:0072523 |
213 |
0.022
|
|
|
|
regulation of presynaptic membrane organization
|
GO:1901629 |
3 |
0.022
|
|
|
|
nuclear transport
|
GO:0051169 |
139 |
0.022
|
|
|
|
low density lipoprotein particle clearance
|
GO:0034383 |
8 |
0.022
|
|
|
|
ribonucleotide catabolic process
|
GO:0009261 |
208 |
0.022
|
|
|
|
negative regulation of cell projection organization
|
GO:0031345 |
56 |
0.021
|
|
|
|
skin development
|
GO:0043588 |
220 |
0.021
|
|
|
|
hormone secretion
|
GO:0046879 |
128 |
0.021
|
|
|
|
carboxylic acid biosynthetic process
|
GO:0046394 |
86 |
0.021
|
|
|
|
exocytosis
|
GO:0006887 |
121 |
0.021
|
|
|
|
regulation of cellular component size
|
GO:0032535 |
121 |
0.021
|
|
|
|
regulation of reactive oxygen species biosynthetic process
|
GO:1903426 |
2 |
0.021
|
|
|
|
positive regulation of apoptotic process
|
GO:0043065 |
217 |
0.021
|
|
|
|
memory
|
GO:0007613 |
58 |
0.021
|
|
|
|
positive regulation of cell motility
|
GO:2000147 |
116 |
0.021
|
|
|
|
energy derivation by oxidation of organic compounds
|
GO:0015980 |
77 |
0.021
|
|
|
|
limb development
|
GO:0060173 |
166 |
0.021
|
|
|
|
positive regulation of purine nucleotide metabolic process
|
GO:1900544 |
114 |
0.021
|
|
|
|
transmembrane receptor protein serine threonine kinase signaling pathway
|
GO:0007178 |
194 |
0.021
|
|
|
|
sequestering of metal ion
|
GO:0051238 |
19 |
0.021
|
|
|
|
skeletal system morphogenesis
|
GO:0048705 |
203 |
0.020
|
|
|
|
digestive system development
|
GO:0055123 |
200 |
0.020
|
|
|
|
plasma lipoprotein particle remodeling
|
GO:0034369 |
6 |
0.020
|
Human |
|
|
regulation of ossification
|
GO:0030278 |
112 |
0.020
|
|
|
|
response to acid chemical
|
GO:0001101 |
111 |
0.020
|
|
|
|
negative regulation of transferase activity
|
GO:0051348 |
85 |
0.020
|
|
|
|
purine ribonucleoside triphosphate catabolic process
|
GO:0009207 |
199 |
0.020
|
|
|
|
cellular homeostasis
|
GO:0019725 |
240 |
0.020
|
|
|
|
reactive oxygen species biosynthetic process
|
GO:1903409 |
8 |
0.020
|
|
|
|
protein catabolic process
|
GO:0030163 |
221 |
0.020
|
|
|
|
regulation of nucleoside metabolic process
|
GO:0009118 |
130 |
0.020
|
|
|
|
regulation of tube size
|
GO:0035150 |
57 |
0.020
|
|
|
|
cholesterol transport
|
GO:0030301 |
38 |
0.020
|
Human |
|
|
bone resorption
|
GO:0045453 |
38 |
0.020
|
|
|
|
positive regulation of neuron projection development
|
GO:0010976 |
79 |
0.020
|
|
|
|
heterocycle catabolic process
|
GO:0046700 |
280 |
0.020
|
|
|
|
alpha amino acid metabolic process
|
GO:1901605 |
59 |
0.019
|
|
|
|
regulation of vesicle mediated transport
|
GO:0060627 |
139 |
0.019
|
|
|
|
regulation of cholesterol esterification
|
GO:0010872 |
2 |
0.019
|
|
|
|
lipoprotein catabolic process
|
GO:0042159 |
7 |
0.019
|
|
|
|
protein ubiquitination
|
GO:0016567 |
171 |
0.019
|
|
|
|
inositol lipid mediated signaling
|
GO:0048017 |
41 |
0.019
|
|
|
|
endocytosis
|
GO:0006897 |
168 |
0.019
|
|
|
|
organelle assembly
|
GO:0070925 |
177 |
0.019
|
|
|
|
negative regulation of apoptotic signaling pathway
|
GO:2001234 |
104 |
0.019
|
|
|
|
response to extracellular stimulus
|
GO:0009991 |
127 |
0.019
|
|
|
|
protein localization to organelle
|
GO:0033365 |
185 |
0.019
|
|
|
|
positive regulation of fatty acid biosynthetic process
|
GO:0045723 |
3 |
0.019
|
|
|
|
bone morphogenesis
|
GO:0060349 |
78 |
0.019
|
|
|
|
norepinephrine transport
|
GO:0015874 |
2 |
0.019
|
|
|
|
metanephric mesenchymal cell migration
|
GO:0035789 |
2 |
0.019
|
|
|
|
tissue migration
|
GO:0090130 |
68 |
0.019
|
|
|
|
inorganic cation transmembrane transport
|
GO:0098662 |
207 |
0.019
|
|
|
|
glucose transport
|
GO:0015758 |
56 |
0.019
|
|
|
|
appendage development
|
GO:0048736 |
166 |
0.019
|
|
|
|
jak stat cascade
|
GO:0007259 |
42 |
0.019
|
|
|
|
lipid transport
|
GO:0006869 |
98 |
0.019
|
Human |
|
|
complement activation
|
GO:0006956 |
16 |
0.018
|
|
|
|
neuron projection guidance
|
GO:0097485 |
141 |
0.018
|
|
|
|
positive regulation of cell adhesion
|
GO:0045785 |
80 |
0.018
|
|
|
|
cellular calcium ion homeostasis
|
GO:0006874 |
119 |
0.018
|
|
|
|
positive regulation of cell migration
|
GO:0030335 |
109 |
0.018
|
|
|
|
positive regulation of lipid storage
|
GO:0010884 |
10 |
0.018
|
|
|
|
leukocyte differentiation
|
GO:0002521 |
342 |
0.018
|
|
|
|
insulin receptor signaling pathway
|
GO:0008286 |
49 |
0.018
|
|
|
|
response to reactive oxygen species
|
GO:0000302 |
56 |
0.018
|
|
|
|
regulation of vasculature development
|
GO:1901342 |
88 |
0.018
|
|
|
|
cellular response to lipid
|
GO:0071396 |
145 |
0.018
|
|
|
|
response to glucagon
|
GO:0033762 |
3 |
0.018
|
|
|
|
action potential
|
GO:0001508 |
78 |
0.018
|
|
|
|
regulation of leukocyte differentiation
|
GO:1902105 |
159 |
0.018
|
|
|
|
regulation of adrenergic receptor signaling pathway
|
GO:0071877 |
4 |
0.018
|
|
|
|
cardiac septum development
|
GO:0003279 |
59 |
0.018
|
|
|
|
regulation of norepinephrine secretion
|
GO:0014061 |
2 |
0.018
|
|
|
|
inorganic ion transmembrane transport
|
GO:0098660 |
234 |
0.018
|
|
|
|
developmental growth involved in morphogenesis
|
GO:0060560 |
138 |
0.018
|
|
|
|
cellular carbohydrate metabolic process
|
GO:0044262 |
119 |
0.018
|
|
|
|
cholesterol efflux
|
GO:0033344 |
24 |
0.018
|
|
|
|
purine nucleoside catabolic process
|
GO:0006152 |
205 |
0.018
|
|
